Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells

J Virol. 2015 Nov;89(22):11692-705. doi: 10.1128/JVI.02018-15. Epub 2015 Sep 9.

Abstract

There is no licensed vaccine against respiratory syncytial virus (RSV) since the failure of formalin-inactivated RSV (FI-RSV) due to its vaccine-enhanced disease. We investigated immune correlates conferring protection without causing disease after intranasal immunization with virus-like particle vaccine containing the RSV fusion protein (F VLP) in comparison to FI-RSV and live RSV. Upon RSV challenge, FI-RSV immune mice showed severe weight loss, eosinophilia, and histopathology, and RSV reinfection also caused substantial RSV disease despite their viral clearance. In contrast, F VLP immune mice showed least weight loss and no sign of histopathology and eosinophilia. High levels of interleukin-4-positive (IL-4(+)) and tumor necrosis factor alpha-positive (TNF-α(+)) CD4(+) T cells were found in FI-RSV immune mice, whereas gamma interferon-positive (IFN-γ(+)) and TNF-α(+) CD4(+) T cells were predominantly detected in live RSV-infected mice. More importantly, in contrast to FI-RSV and live RSV that induced higher levels of CD11b(+) dendritic cells, F VLP immunization induced CD8α(+) and CD103(+) dendritic cells, as well as F-specific IFN-γ(+) and TNF-α(+) CD8(+) T cells. These results suggest that F VLP can induce protection without causing pulmonary RSV disease by inducing RSV neutralizing antibodies, as well as modulating specific subsets of dendritic cells and CD8 T cell immunity.

Importance: It has been a difficult challenge to develop an effective and safe vaccine against respiratory syncytial virus (RSV), a leading cause of respiratory disease. Immune correlates conferring protection but preventing vaccine-enhanced disease remain poorly understood. RSV F virus-like particle (VLP) would be an efficient vaccine platform conferring protection. Here, we investigated the protective immune correlates without causing disease after intranasal immunization with RSV F VLP in comparison to FI-RSV and live RSV. In addition to inducing RSV neutralizing antibodies responsible for clearing lung viral loads, we show that modulation of specific subsets of dendritic cells and CD8 T cells producing T helper type 1 cytokines are important immune correlates conferring protection but not causing vaccine-enhanced disease.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antibodies, Neutralizing / blood
  • Antibodies, Viral / blood
  • Antigens, CD / metabolism
  • CD11b Antigen / metabolism
  • CD8 Antigens / metabolism
  • CD8-Positive T-Lymphocytes / immunology
  • Cell Line
  • Dendritic Cells / immunology*
  • Female
  • Humans
  • Immunization
  • Integrin alpha Chains / metabolism
  • Interferon-gamma / metabolism
  • Interleukin-4 / metabolism
  • Lung / pathology
  • Lung / virology
  • Lung Diseases / immunology
  • Lung Diseases / virology
  • Mice
  • Mice, Inbred BALB C
  • Recombinant Fusion Proteins / immunology
  • Respiratory Syncytial Virus Infections / immunology
  • Respiratory Syncytial Virus Infections / prevention & control
  • Respiratory Syncytial Virus Vaccines / adverse effects
  • Respiratory Syncytial Virus Vaccines / immunology*
  • Respiratory Syncytial Virus, Human
  • Sf9 Cells
  • Spodoptera
  • Th1 Cells / immunology*
  • Tumor Necrosis Factor-alpha / metabolism
  • Vaccines, Virus-Like Particle / immunology*
  • Viral Fusion Proteins / immunology*
  • Viral Load / immunology

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Antigens, CD
  • CD11b Antigen
  • CD8 Antigens
  • F protein, human respiratory syncytial virus
  • Integrin alpha Chains
  • Recombinant Fusion Proteins
  • Respiratory Syncytial Virus Vaccines
  • Tumor Necrosis Factor-alpha
  • Vaccines, Virus-Like Particle
  • Viral Fusion Proteins
  • alpha E integrins
  • Interleukin-4
  • Interferon-gamma